Immix Biopharma Inc. (IMMX)
NASDAQ: IMMX
· Real-Time Price · USD
2.01
-0.04 (-1.95%)
At close: Sep 25, 2025, 3:59 PM
2.05
1.99%
After-hours: Sep 25, 2025, 05:28 PM EDT
-1.95% (1D)
| Bid | 1.5 |
| Market Cap | 57.9M |
| Revenue (ttm) | 96.29K |
| Net Income (ttm) | -23.13M |
| EPS (ttm) | -0.77 |
| PE Ratio (ttm) | -2.61 |
| Forward PE | -2.7 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 2.59 |
| Volume | 128,051 |
| Avg. Volume (20D) | 213,893 |
| Open | 2.07 |
| Previous Close | 2.05 |
| Day's Range | 1.99 - 2.10 |
| 52-Week Range | 1.26 - 3.20 |
| Beta | 0.25 |
| Ex-Dividend Date | n/a |
About IMMX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IMMX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IMMX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+15.31%
IMMX stock has given up its prior gain. Immix Biop...
Unlock content with
Pro Subscription
4 months ago
+15.31%
Immix Biopharma shares are trading higher after the company announced the publication of cell therapy NXC-201 Abstract #7508, selected for oral presentation at the 2025 American Society of Clinical Oncology Annual Meeting.
